Palmetto General Hospital Stroke Patient Outcomes
2023 Outcomes
1. Alteplase Arrival & Treat
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
2. Early Antithrombotic therapy
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
3. VTE Prophylaxis
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
4. Antithrombotic therapy at discharge
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
5. Anticoagulation therapy for atrial fibrillation/fl
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
6. Intensive Statin
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
7. Smoking Cessation Counseling
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
8. Defect Free Care
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
9. Door To Needle Time Within 60 Minutes
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
10. Door To Needle Time Within 45 Minutes
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
11. Door to CT Time Within 25 Minutes (at all times)
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
12. Door to CT Time Within 25 Minutes (arriving in 24 hours)
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
13. Percent EVT (arriving in 24 hrs)
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
14. Modified Rankin Score at Discharge 0 to 2
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
15. Able to ambulate independently at discharge
Alteplase injections are used to dissolve blot clots that have formed in the blood vessels. This metric measures patients who arrive at hospital within 3.5 hours of symptom onset and are treated by hour 4.5 (administration of this drug after this time frame presents risks and safety concerns due to the lack of data and research).
2023 Data Palmetto Stroke Stats
Door to IV Thrombolytic Therapy: (From patient arrival to administration time of an IV clot buster during an acute ischemic stroke that presents within 4.5 hours of symptom onset or last known well.)
(American Heart Association recommends 60 minutes from patient arrival time.)
- Door to IV Thrombolytic Therapy for 2023: 46-minute median average treatment time
- Door to IV Thrombolytic Therapy for 2023: 38-minute mean average treatment time
Door to Groin: (From patient arrival to femoral access/stick time to begin mechanical thrombectomy (removal of clot) during an acute ischemic stroke.)
(American Heart Association recommends 75 minutes door-to-groin access time for mechanical thrombectomies.)
- Door to Groin (Endovascular Treatment Time for Mechanical Thrombectomy): 54-minute median average time
- Door to Groin (Endovascular Treatment Time for Mechanical Thrombectomy): 58-minute mean average time
Door to Reperfusion: (From patient arrival to reperfusion time after clot is removed from the ischemic/target vessel during a stroke.)
(American Heart Association recommends 120 minutes door-to-reperfusion time for mechanical thrombectomies.)
- Door to Reperfusion (Endovascular Treatment Time for Mechanical Thrombectomy Post Recanalization of Target Ischemic Vessel): 92-minute median average time
- Door to Reperfusion (Endovascular Treatment Time for Mechanical Thrombectomy Post Recanalization of Target Ischemic Vessel): 100-minute mean average time
2024 Data Palmetto Stroke Stats
Door to IV Thrombolytic Therapy: (From patient arrival to administration time of an IV clot buster during an acute ischemic stroke that presents within 4.5 hours of symptom onset or last known well.)
(American Heart Association recommends 60 minutes from patient arrival time.)
- Door to IV Thrombolytic Therapy for 2024: 25-minute median average treatment time
- Door to IV Thrombolytic Therapy for 2024: 32-minute mean average treatment time
Door to Groin: (From patient arrival to femoral access/stick time to begin mechanical thrombectomy (removal of clot) during an acute ischemic stroke.)
(American Heart Association recommends 75 minutes door-to-groin access time for mechanical thrombectomies.)
- Door to Groin (Endovascular Treatment Time for Mechanical Thrombectomy): 46-minute median average time
- Door to Groin (Endovascular Treatment Time for Mechanical Thrombectomy): 52-minute mean average time
Door to Reperfusion: (From patient arrival to reperfusion time after clot is removed from the ischemic/target vessel during a stroke.)
(American Heart Association recommends 120 minutes door-to-reperfusion time for mechanical thrombectomies.)
- Door to Reperfusion (Endovascular Treatment Time for Mechanical Thrombectomy Post Recanalization of Target Ischemic Vessel): 79-minute median average time
- Door to Reperfusion (Endovascular Treatment Time for Mechanical Thrombectomy Post Recanalization of Target Ischemic Vessel): 85-minute mean average time